Vimarsana
Biggest News Aggregation in the World

Cyclo Program Steering Committee News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cyclo Program Steering Committee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cyclo Program Steering Committee Today - Breaking & Trending Today

Cyclo Therapeutics Announces Publication of Phase 1 Data for Trappsol Cyclo for the Treatment of Niemann-Pick Disease Type C1 (NPC1) - Vimarsana News

Cyclo Therapeutics Announces Publication of Phase 1 Data for Trappsol Cyclo for the Treatment of Niemann-Pick Disease Type C1 (NPC1)

Published: October 18, 2022

18.10.2022 - Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical-stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, ... Seite 1

Source: wallstreet-online.de
Related Topics:
Caroline HastingsCompany PhaseTrappsol Cyclo Program Steering CommitteeSociety For Inherited Metabolic DisordersCyclo Therapeutics IncGlobal Principal Investigator For The CompanyCyclo TherapeuticsTrappsol CycloNiemann Pick DiseaseInherited MetabolicMolecular GeneticsCyclo Program Steering CommitteeGlobal Principal Investigator
JTC Team, LLC: JTC Team to Host Virtual Investor Niemann-Pick Disease Type C Spotlight Event Featuring Cyclo Therapeutics - Vimarsana News

JTC Team, LLC: JTC Team to Host Virtual Investor Niemann-Pick Disease Type C Spotlight Event Featuring Cyclo Therapeutics

Published: May 12, 2022

- Live video webcast with moderated fireside chat with members of the Cyclo Therapeutics leadership team and Global Principal Investigator for the Phase 3 study, Professor Caroline Hastings, MD, on Monday

Source: finanznachrichten.de
Related Topics:
Jenene ThomasLori Mckenna GorskiLise Lund KjemsCaroline HastingsCyclo Therapeutics IncGlobal Principal Investigator For The CompanyChildren Hospital Research Center OaklandLife SciencesCyclo Program Steering CommitteeCyclo TherapeuticsGlobal Principal InvestigatorProfessor Caroline HastingsSpotlight Event Featuring Cyclo TherapeuticsChief Medical OfficerGlobal HeadPatient AdvocacyHospital OaklandPediatric Hematology OncologyResearch Center Oakland